UB Paderborn / Katalog / Suche / in CDI

1 – 10 von 10

Sortiert nach

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e001999

2021

Volltextzugriff (PDF)

Trastuzumab-related cardiac events in the treatment of early breast cancer

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.1-7

2013

Volltextzugriff (PDF)

dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50

Clinical lung cancer, 2022-03, Vol.23 (2), p.122-134

2022

Volltextzugriff (PDF)

ALK -Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

Clinical lung cancer, 2017-03, Vol.18 (2), p.156-161

2017

Volltextzugriff (PDF)

Post-irradiation angiosarcoma of the breast: clinical presentation and outcome in a series of six cases

Breast Cancer Research and Treatment, 2015-08, Vol.153 (1), p.3-8

2015

Volltextzugriff (PDF)

Favourable health-related quality of life reported in survivors of thymic malignancies

European journal of cardio-thoracic surgery, 2019-02, Vol.55 (2), p.292-299

2019

Volltextzugriff (PDF)

Rising Incidence of Lung Cancer in Arab Females, Jewish Females, and Arab Males from 1990 to 2014 in Israel

The Israel Medical Association journal, 2020-12, Vol.22 (12), p.788-793

2020

Volltextzugriff (PDF)

RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients

Clinical lung cancer, 2017-07, Vol.18 (4), p.e223-e232

2017

Volltextzugriff (PDF)

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non–Small-Cell Lung Cancer: Findings From a Real-Life Cohort

Clinical lung cancer, 2019-07, Vol.20 (4), p.278-286.e1

2019

Volltextzugriff (PDF)

Pegfilgrastim overdose: case report and review of the literature

Medical oncology (Northwood, London, England), 2011-12, Vol.28 (Suppl 1), p.697-698

2011

Volltextzugriff (PDF)

1 – 10 von 10

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(10)

Sprache

Englisch
(10)

Erscheinungsjahr

n.n

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

Trastuzumab-related cardiac events in the treatment of early breast cancer

dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50

ALK -Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

Post-irradiation angiosarcoma of the breast: clinical presentation and outcome in a series of six cases

Favourable health-related quality of life reported in survivors of thymic malignancies

Rising Incidence of Lung Cancer in Arab Females, Jewish Females, and Arab Males from 1990 to 2014 in Israel

RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non–Small-Cell Lung Cancer: Findings From a Real-Life Cohort

Pegfilgrastim overdose: case report and review of the literature

Aktive Filter

Suchergebnisse filtern